Gurlek, F., and E. Tasdemir. “Is It an Advantage or Disadvantage to Usage Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in COVID-19 Patients?”. International Journal of Research in Medical Sciences, vol. 8, no. 12, Nov. 2020, pp. 4200-5, doi:10.18203/2320-6012.ijrms20205289.